Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Profit growth above 25%EBITDA margin expansionExceptional itemResults View source PDF Explain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.4%Reaction day

₹1093.15

prior close

₹1068.25

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.3%-6.7% vs market

Hospital peers, median of 24sector+0.2%-6.7% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty 100 and 6.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.7

10m

-3.9

15m

-4.7

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.4+0.3-6.7+0.2-6.7

Next day

-8.5+1.6-10.1+0.6-9.1

-9.2+1.3-10.4+0.4-9.6

-9.0+1.5-10.5-0.5-8.4

-11.7+0.0-11.8+0.6-12.4

-13.7-0.8-12.9-0.2-13.5

-11.7-0.8-11.0+0.7-12.4

15d

-5.8+1.3-7.0-0.2-5.5

-0.0+2.5-2.5+3.0-3.0

-1.1+1.9-3.0+2.7-3.8

-9.4+3.1-12.5+5.6-15.0

UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare reported strong FY26 consolidated results with revenue from operations growing 19.1% to ₹8,37,345 lakhs from ₹7,02,846 lakhs in FY25. Profit after tax surged 34.1% to ₹1,44,241 lakhs versus ₹1,07,588 lakhs, driven by operational efficiency and a one-time tax benefit of ₹14,148 lakhs from the completed merger of Crosslay Remedies with Jaypee Healthcare (effective December 15, 2025). Exceptional items of ₹4,824 lakhs included ₹3,390 lakhs towards new Labour Codes impact and ₹1,434 lakhs stamp duty provision. The board recommended a dividend of ₹2 per share and approved construction of a new 712-bed hospital in Lucknow. Auditors issued an unmodified opinion with no qualifications.

Likely market impact

The company delivered robust double-digit growth in both revenue and profitability, indicating strong operational execution. The completed merger, new hospital construction, and recent acquisition of Kalinga Hospitals in Bhubaneswar signal expansion plans that could drive future growth. The clean audit opinion with no going concern issues is positive for investor confidence.